Xencor director sells 6,843 shares under 10b5-1

Xencor Inc director Ellen Feigal reported an open-market sale of 6,843 shares of Common Stock at $13.06 per share.

Rhea-AI Filing Summary

Xencor Inc director Ellen Feigal reported an open-market sale of 6,843 shares of Common Stock at $13.06 per share. The transaction was executed on June 18, 2026 pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on June 26, 2025. Following this sale, Feigal holds 12,340 shares directly.

Insider Trade Summary 10b5-1

Net Seller: 6,843 shares

Net Sell 1 txn

Insider Feigal Ellen

Role Director

Sold 6,843 shs ($89K)

Type	Security	Shares	Price	Value
Sale	Common Stock	6,843	$13.06	$89K

Holdings After Transaction: Common Stock — 12,340 shares (Direct)

Footnotes (1)

1. F1. This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 26, 2025.

Key Figures

Shares sold: 6,843 shares Sale price: $13.06 per share Shares held after sale: 12,340 shares +2 more

5 metrics

Shares sold 6,843 shares Open-market sale on June 18, 2026

Sale price $13.06 per share Price for Common Stock sold

Shares held after sale 12,340 shares Direct ownership following transaction

Transactions classified as sales 1 transaction Form 4 transaction summary

Net buy/sell shares -6,843 shares Net-sell direction in transaction summary

Key Terms

Rule 10b5-1, open-market sale, Form 4, Common Stock

4 terms

Rule 10b5-1 regulatory

"This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Xencor (XNCR) director Ellen Feigal report?

Ellen Feigal reported an open-market sale of 6,843 Xencor Common Stock shares. The sale occurred at $13.06 per share on June 18, 2026, and was disclosed on a Form 4 insider trading report filed with regulators.

At what price did Ellen Feigal sell Xencor (XNCR) shares and how many?

She sold 6,843 Xencor Common Stock shares at $13.06 per share. This was an open-market transaction reported as a sale on Form 4, reflecting a planned disposition under a Rule 10b5-1 trading plan.

How many Xencor (XNCR) shares does Ellen Feigal own after this transaction?

After the reported sale, Ellen Feigal directly holds 12,340 Xencor Common Stock shares. This figure represents her remaining direct ownership position as reported in the Form 4 following the June 18, 2026 transaction.

Was Ellen Feigal’s Xencor (XNCR) share sale made under a Rule 10b5-1 plan?

Yes. The footnote explains the transaction was made pursuant to a Rule 10b5-1 trading plan. That plan was adopted by Ellen Feigal on June 26, 2025, indicating the sale was pre-arranged rather than timed discretionarily.

What type of security did Ellen Feigal trade in this Xencor (XNCR) Form 4?

The transaction involved Xencor Common Stock, a non-derivative security. The Form 4 shows no derivative securities transactions or remaining derivative positions, only this single open-market sale of common shares.

What does the Form 4 net-sell summary show for Xencor (XNCR) director Ellen Feigal?

The transaction summary shows a net sale of 6,843 shares, with one sell transaction and no purchases. It classifies the activity as a net-sell direction, reflecting only this open-market sale and no offsetting acquisitions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Feigal Ellen

(Last) (First) (Middle)

C/O XENCOR, INC.

465 N HALSTEAD STREET, SUITE 200

(Street)

PASADENA CALIFORNIA 91107

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Xencor Inc [ XNCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2026		S(1)		6,843	D	$13.06	12,340	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction is pursuant to a 10b5-1 plan adopted by the Reporting Person on June 26, 2025.

Remarks:

	/s/ Celia E. Eckert, Attorney-in-Fact	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)